Table 2 Comparison of behavioral and objective gait outcome measures
From: Effect of cerebrospinal dual-site magnetic stimulation on freezing of gait in Parkinson’s disease
Outcomes | Group | Baseline | Post | Post1m |
|---|---|---|---|---|
Primary outcome measure | ||||
FOG-Q | DS | 17.11 ± 4.15 | 13.05 ± 4.03*** | 13.74 ± 4.03*** |
SS | 16.33 ± 4.61 | 14.11 ± 3.66*** | 14.94 ± 4.08** | |
NS | 17.78 ± 4.10 | 18.22 ± 4.12 | 18.67 ± 4.06 | |
Secondary outcome measures | ||||
UPDRS-III | DS | 28.47 ± 11.82 | 22.63 ± 9.56*** | 22.79 ± 9.07*** |
SS | 32.94 ± 8.03 | 27.0 ± 7.33*** | 27.56 ± 7.45*** | |
NS | 29.44 ± 11.41 | 29.61 ± 11.88 | 30.94 ± 12.11 | |
Gait speed, m/s | DS | 0.55 ± 0.19 | 0.71 ± 0.18*** | 0.70 ± 0.19*** |
SS | 0.58 ± 0.25 | 0.67 ± 0.26** | 0.62 ± 0.25 | |
NS | 0.51 ± 0.27 | 0.45 ± 0.21 | 0.42 ± 0.27* | |
Stride length, cm | DS | 58.28 ± 19.34 | 75.01 ± 19.07*** | 72.62 ± 18.64*** |
SS | 64.50 ± 26.72 | 71.54 ± 27.90 | 66.58 ± 28.48 | |
NS | 56.25 ± 28.45 | 48.48 ± 21.17* | 45.25 ± 27.98** | |
Stride time variability, % | DS | 8.10 ± 5.44 | 6.14 ± 5.39 | 5.96 ± 5.20 |
SS | 7.42 ± 5.66 | 8.35 ± 5.95 | 8.42 ± 5.30 | |
NS | 9.74 ± 5.53 | 10.85 ± 5.57 | 12.51 ± 10.43 | |
Double support time percentage, % | DS | 26.76 ± 8.29 | 22.31 ± 6.21** | 22.66 ± 5.89 |
SS | 29.88 ± 9.53 | 25.99 ± 7.98* | 27.79 ± 7.44 | |
NS | 31.73 ± 12.54 | 31.83 ± 9.50 | 36.56 ± 12.57** | |
